$KOPN
KOPIN CORP Stock $kopn

$kopn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016379 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2022 Q1
Revenue	$473.5K	$11.58M
YoY Change	-96.02%	-0.87%
Cost Of Revenue	$6.624M	$7.783M
YoY Change	-16.22%	21.61%
Gross Profit	$4.134M	$3.796M
YoY Change	3.28%	-28.11%
Gross Profit Margin	873.09%	32.78%
Selling, General & Admin	$4.648M	$4.465M
YoY Change	7.41%	-24.46%
% of Gross Profit	112.43%	117.63%
Research & Development	$2.312M	$5.409M
YoY Change	-55.06%	51.93%
% of Gross Profit	55.93%	142.5%
Depreciation & Amortization	$224.6K	$267.6K
YoY Change	-16.1%	27.42%
% of Gross Profit	5.43%	7.05%
Operating Expenses	$13.58M	$9.873M
YoY Change	-21.83%	4.26%
Operating Profit	-$2.826M	-$6.078M
YoY Change	-48.33%	45.05%
Interest Expense	$199.7K	$4.742M
YoY Change	-245.17%	11755.25%
% of Operating Profit
Other Income/Expense, Net	$236.7K	-$1.140K
YoY Change	-267.72%
Pretax Income	-$2.590M	-$1.337M
YoY Change	-53.85%	-67.79%
Income Tax	$39.00K	$36.00K
% Of Pretax Income
Net Earnings	-$2.629M	-$1.373M
YoY Change	-53.45%	-67.21%
Net Earnings / Revenue	-555.13%	-11.86%
Basic Earnings Per Share	-$0.03	-$0.02
Diluted Earnings Per Share	-$0.03	-$15.23K
COMMON SHARES
Basic Shares Outstanding	105.0M shares	90.12M shares
Diluted Shares Outstanding	105.0M shares

Balance Sheet

Concept	2023 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.61M	$26.32M
YoY Change	59.55%	-26.07%
Cash & Equivalents	$8.583M	$21.87M
Short-Term Investments	$21.03M	$4.451M
Other Short-Term Assets	$1.712M	$2.214M
YoY Change	-24.3%	10.71%
Inventory	$6.818M	$7.133M
Prepaid Expenses
Receivables	$5.613M	$9.330M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$46.80M	$44.99M
YoY Change	16.8%	-13.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.826M	$5.570M
YoY Change	5.01%	74.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.728M	$9.554M
YoY Change	-21.4%	112.3%
Other Assets	$169.1K	$170.9K
YoY Change	-1.05%	-14.54%
Total Long-Term Assets	$12.73M	$15.29M
YoY Change	-17.92%	93.6%
TOTAL ASSETS
Total Short-Term Assets	$46.80M	$44.99M
Total Long-Term Assets	$12.73M	$15.29M
Total Assets	$59.52M	$60.29M
YoY Change	7.11%	0.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.836M	$5.865M
YoY Change	-21.07%	4.73%
Accrued Expenses	$5.854M	$6.497M
YoY Change	1.73%	20.32%
Deferred Revenue	$718.5K
YoY Change	-76.42%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.75M	$17.07M
YoY Change	-21.34%	10.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.361M	$4.516M
YoY Change	-32.48%	105.26%
Total Long-Term Liabilities	$1.361M	$4.516M
YoY Change	-32.48%	105.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.75M	$17.07M
Total Long-Term Liabilities	$1.361M	$4.516M
Total Liabilities	$16.63M	$21.42M
YoY Change	-17.61%	22.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$341.0M
YoY Change	4.58%
Common Stock	$1.100M
YoY Change	19.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$103.1K
YoY Change
Treasury Stock Shares
Shareholders Equity	$42.90M	$38.87M
YoY Change
Total Liabilities & Shareholders Equity	$59.52M	$60.29M
YoY Change	7.11%	0.65%

Cashflow Statement

Concept	2023 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.629M	-$1.373M
YoY Change	-53.45%	-67.21%
Depreciation, Depletion And Amortization	$224.6K	$267.6K
YoY Change	-16.1%	27.42%
Cash From Operating Activities	-$4.175M	-$2.283M
YoY Change	-54.4%	813.06%
INVESTING ACTIVITIES
Capital Expenditures	$216.6K	-$524.4K
YoY Change	-368.86%	49.82%
Acquisitions
YoY Change
Other Investing Activities	-$1.000K	-$2.000M
YoY Change	-99.9%	-1100.02%
Cash From Investing Activities	-$16.84M	-$2.524M
YoY Change	1464.74%	1582.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$21.34M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$21.34M	-95.61K
YoY Change	952.49%	-100.62%
NET CHANGE
Cash From Operating Activities	-$4.175M	-2.283M
Cash From Investing Activities	-$16.84M	-2.524M
Cash From Financing Activities	$21.34M	-95.61K
Net Change In Cash	$324.3K	-4.903M
YoY Change	-103.95%	-132.49%
FREE CASH FLOW
Cash From Operating Activities	-$4.175M	-$2.283M
Capital Expenditures	$216.6K	-$524.4K
Free Cash Flow	-$4.391M	-$1.758M
YoY Change	-51.61%	-1858.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	City Area Code CityAreaCode	(508)
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	870-5959
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	170132	usd
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01
CY2023Q2	dei	Trading Symbol TradingSymbol	KOPN
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109901024	shares
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000771266
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2022Q4	KOPN	Customer Deposit Current CustomerDepositCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2023Q2	us-gaap	Revenue Related And Nonrelated Party Status Extensible Enumeration RevenueRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Revenue Related And Nonrelated Party Status Extensible Enumeration RevenueRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
CY2023Q2	us-gaap	Accounts Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Accounts Payable Related And Nonrelated Party Status Extensible Enumeration AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Accounts Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Accounts Payable Related And Nonrelated Party Status Extensible Enumeration AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent		usd
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-01
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	0-19882
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	KOPIN CORPORATION
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2833935
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	125 North Drive
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Westborough
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8583146	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8258878	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	21027050	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4388778	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	800000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	303000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5612935	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6537891	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3043076	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4068364	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6817754	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6426400	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	127280	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	105495	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1584669	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1074867	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	46795910	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30860673	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1826093	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1831641	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3005772	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3168520	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	169132	usd
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01581-3335
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109901024	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92883524	shares
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	7727789	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7721206	usd
CY2023Q2	us-gaap	Assets Assets	59524696	usd
CY2022Q4	us-gaap	Assets Assets	43752172	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3836276	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5438980	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1778133	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2879139	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2166340	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1966000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	718544	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	930500	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	790567	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	786928	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	790000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	790000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1118969	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182346	usd
CY2023Q2	KOPN	Customer Deposit Current CustomerDepositCurrent	87283	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	466246	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	482739	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11752358	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14456632	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	252971	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	248284	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2378248	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2576883	usd
CY2023Q2	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	882500	usd
CY2022Q4	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	1110000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1361142	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1369758	usd
CY2023Q2	us-gaap	Liabilities Liabilities	16627219	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19761557	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111502604	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94920060	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1099715	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	929540	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381753964	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	360567631	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1182295	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1176068	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-341035370	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338406815	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	42897477	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24163297	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-172682	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42897477	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59524696	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43752172	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758191	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11578422	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6624101	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7782879	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2312217	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5408613	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4648130	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4464548	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13584448	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	17656040	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2826257	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6077618	usd
CY2023Q2	us-gaap	Interest Income Operating InterestIncomeOperating	101765	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	6980	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37030	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1141	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	4700000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	97907	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	35115	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	236702	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4740954	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2589555	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1336664	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1372664	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-23	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2628555	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1372641	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105036382	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90121226	shares
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1372664	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9994	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5932	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3767	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-107451	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	523	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6227	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113906	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2622328	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1486570	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-23	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2622328	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1486547	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	194190	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6227	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21335000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42897477	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39626857	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	656073	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113906	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113906	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	95613	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1372664	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38700747	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1372664	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	224574	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	267590	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	128	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	194190	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	656073	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-202671	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	4700000	usd
CY2023Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	39105	usd
CY2022Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	35836	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	118697	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	16351	usd
CY2023Q2	KOPN	Increase Decreasein Allowancefor Credit Losses IncreaseDecreaseinAllowanceforCreditLosses	495000	usd
CY2022Q1	KOPN	Increase Decreasein Allowancefor Credit Losses IncreaseDecreaseinAllowanceforCreditLosses	-26281	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	292405	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	588175	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-453262	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	420919	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5777308	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-934759	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	252809	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	665589	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1156461	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	525705	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	314361	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1983304	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-107657	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-211815	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2317122	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4174551	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2282663	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	216618	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	524368	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17624779	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3000030	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1000000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1000000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16840397	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2524398	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21335000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	95613	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21335000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95613	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4216	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-17765	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	324268	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4920439	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8258878	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26787931	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8583146	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21867492	usd
CY2023Q2	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_803_eus-gaap--BasisOfAccounting_z5WHwDQo0Y3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_825_zswqJTafxnbc">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of April 1, 2023 and for the three month periods ended April 1, 2023 and March 26, 2022 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The consolidated financial statements for the three months ended April 1, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. The consolidated financial statements for the three months ended March 26, 2022 include the accounts of Kopin Corporation, its wholly owned subsidiaries, and a majority owned <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_c20220326__srt--OwnershipAxis__custom--EMDTMember_zKMuHZVh8Rh5" title="Subsidary percentage">80</span>% subsidiary, eMDT America Inc. (“eMDT”). Kopin acquired the remaining <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_c20230401__srt--OwnershipAxis__custom--EMDTMember_z6CwkuwYwNBg" title="Subsidary percentage">20</span>% of eMDT during the three months ended April 1, 2023. Net loss attributable to noncontrolling interest in the Company’s consolidated statements of operations for the three months ended March 26, 2022 represents the <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220326__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EMDTMember_zwZ7A4GYiJ75" title="Equity ownership percentage">20</span>% of the results of operations which is allocated to the shareholders of the equity interests not owned by the Company. All intercompany transactions and balances have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company issued a license to LST for certain technology associated with our Organic Light Emitting Technology, transferred in-process development contracts with two customers and accounts receivables that the Company had previously determined were not collectible. The technology license agreement provides for Kopin to transfer certain patents to LST if LST achieves certain milestones, however upon transfer Kopin will receive a license to the technology. To the extent LST makes improvements to the technology licensed from Kopin, Kopin will receive a license for these improvements for certain markets. Kopin is not obligated to provide any additional funding support to LST. As consideration for the transaction, the Company received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230104__20230105__us-gaap--TypeOfArrangementAxis__custom--LSTAgreementMember__dei--LegalEntityAxis__custom--LightningSiliconTechnologyIncMember_zlrYVU9hYvHk" title="Issuance of shares">18,000,000</span> preferred shares in LST, which the Company determined had no fair value as of the transaction date or as of April 1, 2023. While these shares represent a <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20230105__us-gaap--TypeOfArrangementAxis__custom--LSTAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LightningSiliconTechnologyIncMember_z0Xz6NGljHx9" title="Ownership percentage">20.0%</span> equity stake in LST, they do not provide the Company with voting rights to elect LST’s governance Board. The Company will also receive a royalty based on unit sales of products that utilize the technology licensed. Drs. John Fan, the Company’s former President and CEO and current Chairman of the Board, Boryeu Tsaur, a former Executive Vice President of the Company and Hong Choi, the Company’s former Chief Technology Officer terminated their employment with the Company and became investors in and members of the management team of LST. Dr. Fan is the Founder of LST. As a result of this transaction, in 2022 the Company wrote off the two operating lease assets associated with facilities used for the development of our organic light emitting diode (OLED) products. The Company’s maximum exposure to loss related to its involvement with LST is limited to the value of its investment in LST, which has a carrying value of $0 at April 1, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023, the Company sold <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230126__20230127_zi37N2RTATm6" title="Number of registered common stock sold">17,000,000</span> shares of common stock and pre-funded warrants to purchase up to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zlpjm912hzef" title="Pre-funded warrants issued to purchase common stock">6,000,000</span> shares of common stock at a public offering price of $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zag7j1XRwk87" title="Offering price per share">0.99</span> per share for net proceeds of approximately $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20230126__20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zmfrPQlcnEzg" title="Proceeds from issuance of warrants">21.4</span> million. The Company believes that its existing cash, cash equivalents, will be adequate to satisfy its current operating plans for at least the next twelve months from the issuance of these financial statements. The Company has in the past sold equity securities through at-the-market equity offerings and in the traditional fashion of significant equity offerings. Nonetheless, management monitors the capital markets on an ongoing basis and may consider raising capital if favorable market conditions develop. If the Company</span><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">’</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">s actual results are less than projected or the Company needs to raise capital for additional liquidity, the Company may be required to do additional equity financings, reduce expenses, or enter into a strategic transaction. However, management can make no assurance that the Company will be able to raise additional capital, reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to the Company, or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17000000	shares
CY2022Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	4700000	usd
CY2023Q2	KOPN	Unrealized Loss On Equity Interest UnrealizedLossOnEquityInterest	100000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21124797	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4500018	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-97747	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-111240	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21027050	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4388778	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	13838098	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	7188952	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21027050	usd
CY2023Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	37337985	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	20368862	usd
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5200000	usd
CY2019Q4	us-gaap	Investments Investments	0	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17000000	shares
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4442045	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4285757	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1971239	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1735454	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	404470	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	405189	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6817754	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6426400	usd
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1530945	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1953171	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1965901	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.22
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	200294	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.31
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	617750	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.20
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	17500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.26
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1530945	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.72
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	194190	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	656073	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2600000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1966000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	395000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	195000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2166000	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	135500000	usd
CY2023Q2	KOPN	Net Operating Loss Expiry Period NetOperatingLossExpiryPeriod	expiring 2023 through 2038
CY2023Q2	KOPN	Operating Loss Carryforwards Unlimited OperatingLossCarryforwardsUnlimited	89300000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3043076	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4068364	usd
CY2023Q2	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-1025288	usd
CY2023Q2	KOPN	Percentage Of Change In Contract Assets Current PercentageOfChangeInContractAssetsCurrent	-0.25	pure
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	718544	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	930500	usd
CY2023Q2	KOPN	Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract	211956	usd
CY2023Q2	KOPN	Percentage Contract Liabilities And Billings In Excess Of Revenue Earned PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned	-0.23	pure
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6331	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6190	usd
CY2023Q2	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-141	usd
CY2023Q2	KOPN	Percentage Of Change In Contract Liabilitiesnoncurrent PercentageOfChangeInContractLiabilitiesnoncurrent	0.02	pure
CY2023Q2	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	2318201	usd
CY2022Q4	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	3131674	usd
CY2023Q2	KOPN	Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-813473	usd
CY2023Q2	KOPN	Percentage Of Change In Net Contract Assets Liabilities PercentageOfChangeInNetContractAssetsLiabilities	-0.26	pure
CY2023Q2	KOPN	Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-800000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2900000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17500000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0597	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y5M23D
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	214563	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	249503	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	729950	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	891292	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	638256	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	604000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	604000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	201333	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3668831	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	500016	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3168815	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	790567	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2378248	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3168815	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	248254	usd
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	4832000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	5000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2023Q2	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11578000	usd
CY2022Q1	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10758000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11578000	usd
CY2023Q2	us-gaap	Revenues Revenues	473500	usd
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	39255	usd
CY2022Q1	us-gaap	Revenues Revenues	624216	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	593581	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29600	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	325106	usd

Files In Submission

Name	View Source	Status
kopn-20230401_cal.xml	Edgar Link	unprocessable
kopn-20230401_lab.xml	Edgar Link	unprocessable
0001493152-23-016379-index-headers.html	Edgar Link	pending
0001493152-23-016379-index.html	Edgar Link	pending
0001493152-23-016379.txt	Edgar Link	pending
0001493152-23-016379-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kopn-20230401.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kopn-20230401_def.xml	Edgar Link	unprocessable
kopn-20230401_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOPN
KOPIN CORP Stock $kopn

2023 Q2 Form 10-Q Financial Statement

#000149315223016379 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN KOPIN CORP Stock $kopn

2023 Q2 Form 10-Q Financial Statement

#000149315223016379 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN
KOPIN CORP Stock $kopn